Skip to main content
. 2020 Jun 29;9(7):526. doi: 10.3390/pathogens9070526

Figure 1.

Figure 1

Occurrence of resistance mechanisms to macrolides, lincosamides, and streptogramin B among GBS strains (n = 165): erythromycin sensitive (no resistance mechanism) (n = 115); inductive mechanism of resistance to macrolides, lincosamides, and streptogramin B (MLSB i) (n = 11); constitutive mechanism of resistance to macrolides, lincosamides, and streptogramin B (MLSB c) (n = 30) and M phenotype (n = 9).